| P50 | author | Elisa Borghi | Q38800629 |
| | Elvira Verduci | Q47503975 |
| P2093 | author name string | Giovanni Radaelli | |
| | Giuseppe Banderali | |
| | Francesca Moretti | |
| | Carlotta Lassandro | |
| P2860 | cites work | Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle. | Q38260973 |
| | Nonalcoholic fatty liver disease: a challenge for pediatricians. | Q38288466 |
| | Pediatric hypertension: a growing problem | Q38337278 |
| | Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? | Q38365928 |
| | Viewpoint article: Childhood obesity--looking back over 50 years to begin to look forward | Q39059252 |
| | Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach? | Q39448627 |
| | Skeletal muscle membrane lipids and insulin resistance. | Q41053441 |
| | Quantitative relationship between liver fat content and metabolic syndrome in obese children and adolescents | Q43530958 |
| | Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children. | Q43764680 |
| | Plasma long-chain fatty acids and the degree of obesity in Italian children | Q44630149 |
| | The relationship of insulin resistance with SNP 276G>T at adiponectin gene and plasma long-chain polyunsaturated fatty acids in obese children. | Q45960301 |
| | Diagnostic performance of BMI percentiles to identify adolescents with metabolic syndrome. | Q50728700 |
| | Omega-3 index, obesity and insulin resistance in children. | Q51382020 |
| | Plasma long-chain fatty acids profile and metabolic outcomes in normolipidaemic obese children after one-year nutritional intervention. | Q51384555 |
| | Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. | Q51486823 |
| | PPAR-gamma2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity. | Q51491070 |
| | Docosahexaenoic acid content in plasma phospholipids and desaturase indices in obese children. | Q51506311 |
| | Relationships between the fatty acid composition of muscle and erythrocyte membrane phospholipid in young children and the effect of type of infant feeding. | Q51558030 |
| | Role of dietary fats in the prevention and treatment of the metabolic syndrome. | Q53085331 |
| | Childhood Obesity and Insulin Resistance: How Should It Be Managed? | Q57922118 |
| | Metabolic Syndrome Affects Fatty Acid Composition of Plasma Lipids in Obese Prepubertal Children | Q61687034 |
| | A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease | Q62066986 |
| | Serum phospholipid fatty acids, adipose tissue, and metabolic markers in obese adolescents | Q79393994 |
| | Characteristics of obese children with low content of arachidonic acid in plasma lipids | Q80516949 |
| | Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents | Q81583316 |
| | Childhood obesity | Q87399998 |
| | Childhood obesity and the metabolic syndrome | Q87411975 |
| | Lipid composition of cell membranes and its relevance in type 2 diabetes mellitus | Q27016081 |
| | Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties | Q27028080 |
| | Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome | Q28080989 |
| | What is metabolic syndrome, and why are children getting it? | Q28385817 |
| | Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators | Q29615694 |
| | Epigenetic effects of human breast milk | Q33570511 |
| | Relationship between erythrocyte omega-3 content and obesity is gender dependent. | Q33702778 |
| | Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients | Q34001983 |
| | Chronic inflammation in obesity and the metabolic syndrome | Q34035348 |
| | Atherogenic dyslipidemia and cardiovascular risk factors in obese children | Q34461856 |
| | Omega-3 fatty acids EPA and DHA: health benefits throughout life | Q34635830 |
| | Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease | Q34758939 |
| | Adipose tissue n-3 fatty acids and metabolic syndrome | Q34860352 |
| | Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomised controlled trial | Q34972235 |
| | Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease | Q35088371 |
| | Dyslipidemia and pediatric obesity | Q35563745 |
| | Glucose tolerance and insulin resistance in Indian children: relationship to infant feeding pattern. | Q35571180 |
| | Long-chain polyunsaturated fatty acid status in obesity: a systematic review and meta-analysis | Q35591410 |
| | Plasma and red blood cell fatty acid values as indexes of essential fatty acids in the developing organs of infants fed with milk or formulas | Q35870681 |
| | Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease | Q35904142 |
| | Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids | Q36432334 |
| | What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? | Q36932044 |
| | The metabolic syndrome in children and adolescents - an IDF consensus report | Q36938565 |
| | Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk | Q37115260 |
| | Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. | Q37265323 |
| | Insulin resistance and obesity in childhood | Q37275057 |
| | Docosahexaenoic acid (DHA) and cardiovascular disease risk factors | Q37527301 |
| | Docosahexaenoic acid and lactation | Q37562108 |
| | The differential effects of EPA and DHA on cardiovascular risk factors | Q37846894 |
| | Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. | Q37901598 |
| | The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity | Q37947064 |
| | The prevalence of metabolic syndrome in children: a systematic review of the literature | Q38068227 |
| | Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed | Q38098687 |
| | Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome. | Q38259328 |
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | organic chemistry | Q11351 |
| | lipid | Q11367 |
| | obesity | Q12174 |
| | catalysis | Q82264 |
| | childhood obesity | Q3241451 |
| | metabolic syndrome | Q657193 |
| | physiological phenomenon | Q66615932 |
| | body size | Q66711810 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 19989-20000 | |
| P577 | publication date | 2015-08-21 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link? | |
| P478 | volume | 16 | |